(Q35014059)

5 August 2017

1 reference

title

Genomic and personalized medicine: foundations and applications (English)

1 reference

5 August 2017

personalized medicine

1 reference

Geoffrey S Ginsburg

1

1 reference

PubMed ID

19931193

5 August 2017

Huntington F Willard

series ordinal

2

1 reference

5 August 2017

1 October 2009

1 reference

5 August 2017

Translational Research

1 reference

5 August 2017

154

1 reference

5 August 2017

277-287

1 reference

5 August 2017

6

1 reference

Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

Gail model and breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

Decision tools in health care: focus on the problem, not the solution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

Evaluation of family history as a risk factor and screening tool for detecting undiagnosed diabetes in a nationally representative survey population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

Family history and prevalence of diabetes in the U.S. population: the 6-year results from the National Health and Nutrition Examination Survey (1999-2004).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

Expanding the definition of a positive family history for early-onset coronary heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

Familial risks for cancer as the basis for evidence-based clinical referral and counseling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

Attention-deficit/hyperactivity disorder: a selective overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

Reconsidering the family history in primary care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

New standards and enhanced utility for family health history information in the electronic health record: an update from the American Health Information Community's Family Health History Multi-Stakeholder Workgroup

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

Prospects for personalized cardiovascular medicine: the impact of genomics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

Embracing the complexity of genomic data for personalized medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

The quality of health care delivered to adults in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

From pharmacogenetics to personalized medicine: a vital need for educating health professionals and the community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

A roadmap for national action on clinical decision support

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

Genetic-based dosing in orthopedic patients beginning warfarin therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

Personalized medicine: revolutionizing drug discovery and patient care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

Genomic medicine: genetic variation and its impact on the future of health care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

A HapMap harvest of insights into the genetics of common disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

Gene expression profiling in acute myeloid leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

Molecular diagnosis of Burkitt's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

The pharmacogenetics of coumarin therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

Applications of AmpliChip CYP450.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

Genomic signatures to guide the use of chemotherapeutics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

Blood gene expression profiling in liver transplant recipients with hepatitis C virus and posttransplantation diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

Multiparameter immune profiling of operational tolerance in liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

Molecular Testing in the Management of Cardiac Transplant Recipients: Initial Clinical Experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

The Economic Implications of Noninvasive Molecular Testing for Cardiac Allograft Rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

Whole-genome re-sequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

Sequencers step up to the speed challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

GENE SEQUENCING: The Race for the $1000 Genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

The thousand-dollar genome. Genetic brinkmanship or personalized medicine?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

Letting the genome out of the bottle--will we get our wish?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

Clinical genomic testing: getting it right

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

New clinical trials policy at FDA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

A change in the market--investing in diagnostics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.09.005

10.1016/J.TRSL.2009.09.005

7 January 2021

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

19931193